Article
Genetic variants in LGALS3 are related to lower galectin-3 serum levels and clinical outcomes in systemic sclerosis patients: A case-control study.
Autoimmunity - 1 Jun 2021
Cunha Eudes Gustavo Constantino, de Lima Camilla Albertina Dantas, Vilar Kamila de Melo, Nóbrega Marcelo Francisco de, Almeida Anderson Rodrigues de, Pereira Michelly Cristiny, Dantas Andréa Tavares, Gonçalves Rafaela Silva Guimarães, Rêgo Moacyr Jesus Barreto de Melo, Duarte Angela Luzia Branco Pinto, Pitta Maira Galdino da Rocha
Abstract excerpt
INTRODUCTION: Systemic sclerosis (SSc) is a rare complex disease characterized by vascular damage, autoimmunity, and extensive skin and internal organs fibrosis. Galectin-3 (Gal-3) is encoded by gene LGALS3 (Lectin, Galactoside-Binding, Soluble, 3; 14q22.3) and it has been reported to play a central role in self-tolerance, inflammation, and fibrosis. OBJECTIVE: To investigate associations among LGALS3 single...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
